BioCatalystWatch
BEAMWorkspace / BEAM / OverviewCompany library
Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

Beam Therapeutics Inc. (BEAM)

Website

Price
Market cap
Next catalystDec 15, 2026Risto-cel — BEACON · Phase 1/2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

BEAM-301

G6PC (R83C)

PreINDP1P2P3FilingApproved
BEAM-302

SERPINA1 (PiZ/E342K)

PreINDP1P2P3FilingApproved
Upcoming / outlook

risto-celRisto-cel — BEACON

HBG1 promoter × HBG2 promoter

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

risto-celRisto-cel — BEACON

HBG1 promoter × HBG2 promoter

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

BEAM-302

SERPINA1 (PiZ/E342K)

PreINDP1P2P3FilingApproved
Upcoming / outlook

BEAM-301

G6PC (R83C)

PreINDP1P2P3FilingApproved

Other pipelines

BEAM-304 (in vivo)

PAH

BEAM-103

CD117 (c-KIT)

PreINDP1P2P3FilingApproved
BEAM-103

CD117 (c-KIT)

PreINDP1P2P3FilingApproved
BEAM-103

CD117 (c-KIT)

PreINDP1P2P3FilingApproved
BEAM-104

HBG1/2 × CD117 (c-KIT)

PreINDP1P2P3FilingApproved
BEAM-104

HBG1/2 × CD117 (c-KIT)

PreINDP1P2P3FilingApproved
HbG-Makassar Program

HbS causative point mutation

PreINDP1P2P3FilingApproved
BEAM-102 (ex vivo)

HBB (HbS)

PreINDP1P2P3FilingApproved

Partner / License out

CD19

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BEAM PR & News

PR & News

BEAM SEC archive